In the fifth year since human cloning to generate stem cells was legalised in the UK, what
progress has been made towards taking stem-cell therapy from laboratory to clinical …

Cell based regenerative therapy with stem cells from bone marrow has been reported widely
and used for more than 50 years. 1 However, use of stem cells for regenerative medicine …

In The Lancet, Steven Schwartz and colleagues1 report the first clinical experience of
patients treated with cells derived from human embryonic stem cells (hESCs). A patient with …

The ethical debate about human embryonic stem-cell research has revisited the old embryo-
research debate, which UK law put within a framework as long ago as 1990, 1 licensing it …

Comment because they would otherwise be discarded, they obviate many of the ethical
issues about donation of embryos for research and allow for the generation of disease …

4 Gaspardone A, De Fabritiis, Scaffa R, et al. Stem cell mobilisation after coronary artery
bypass grafting. Ital Heart J 2004; 5 (suppl 1): 23–28. 5 Kang HJ, Kim HS, Zhang SY, et al …

Executive summary In this Commission, we argue that a combination of poor quality science,
unclear funding models, unrealistic hopes, and unscrupulous private clinics threatens …

Comment embryonic stem-cell lines in 1981. 2, 3 Unlike in the mouse, 4 leukaemia-
inhibitory factor was not able to maintain the non-differentiated growth of human embryonic …

Background Human embryonic stem cells are likely to play an important role in the future of
regenerative medicine. However, exposure of existing human embryonic stem-cell lines to …

For personal use only. Reproduce with permission from The Lancet Publishing Group. by a
report describing the development and “overgrowth” of ectodermal and mesenchymal tissue …